Congressman Curtis's timely trades raise eyebrows amid pharma stock surge

Capitol Trades

@capitol2iq

·Follow

Congressman @RepJohnCurtis recently disclosed his acquisition of shares in the pharma firm @EliLillyandCo on Sept 13, which corresponds with the day when its drug Mounjaro received approval from @NHS for its utilization in the treatment of type 2 diabetes. During the same month,…